Skip to main content
2024 Guide to Patient Support Services

MorphoSys

2024 PSS Guide

MorphoSys Patient Support Services

MorphoSys offers the My MISSION Support program to assist patients while taking Monjuvi (Table).

MY MISSION Support

This program has dedicated, specially trained professionals to support patient access to Monjuvi, including a Copay Assistance Program and the MorphoSys Foundation Patient Assistance Program.

Copay Assistance Program

Commercially insured patients taking Monjuvi may be able to receive assistance through the My MISSION Support Copay Assistance Program.

To learn more or to enroll your patient in the Copay Assistance Program, call 855-421-6172 or visit Copay Assistance Program

MorphoSys Foundation Patient Assistance Program

Patients may be able to obtain treatment with Monju­vi at no cost through the MorphoSys Foundation Patient Assistance Program. Eligibility is determined on a case-­­by-case basis.

To learn more or to enroll your patient in the MorphoSys Foundation Patient Assistance Program, call 855-421-6172 or visit MorphoSys Foundation Patient Assistance Program.

TABLE MorphoSys Oncology Drug

Drug
Indication
Patient support programs

Drug
Monjuvi (tafasitamab-cxix) injection
Indication
Treatment, in combination with lenalidomide, of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified, including DLBCL arising from low-grade lymphoma, and who are ineligible for autologous stem-cell transplant
Patient support programs